• Finance Tax Investment

Magdalen College & GIC enter Strategic Partnership to accelerate development of The Oxford Science Park

Oxford, UK, October 5 2021 – Magdalen College Oxford, owner of The Oxford Science Park (TOSP), one of the UK’s leading parks for science and technology companies, and an affiliate of GIC have entered into a Strategic Partnership to accelerate the development of The Oxford Science Park.

SolasCure announces £15m Series A raise

Biotech start-up SolasCure has announced the completion of its Series A investment round, to support the development of their wound cleaning product, Aurase®.

Andrew Mackintosh appointed as new Chair of UK Innovation and Science Seed Fund Advisory Board

The UK Innovation and Science Seed Fund (UKI2S) is pleased to announce the appointment of Dr Andrew Mackintosh as the new Chair of its Advisory Board.

MDC Seeks Buyer for Alderley Park Lighthouse Laboratory

Medicines Discovery Catapult (MDC) today announces its intention to sustain its Alderley Park Lighthouse Laboratory Diagnostics Testing facility (“AP Lighthouse Laboratory”) through new private sector ownership.

Covington Advises Arecor Therapeutics on AIM IPO

LONDON, June 17, 2021 – Covington advised Arecor Therapeutics plc on the admission of its shares to trading on the AIM market of the London Stock Exchange. The IPO raised gross proceeds of £20 million through an oversubscribed placing of ordinary shares giving the company a market capitalisation of approximately £62.5 million.

Iksuda Therapeutics closes $47 million financing round

Funding to accelerate clinical progression of Iksuda’s pipeline of new generation of antibody drug conjugates, targeting tumours with high unmet need Investment round led by Korean-based Mirae Asset Capital and Celltrion

Fieldfisher advises on £20 million fundraising for Diurnal Group

Fieldfisher's top ranked equity capital markets team has advised Panmure Gordon as sole broker on an oversubscribed fundraising for AIM-listed Diurnal Group plc, a specialist pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases.

Magdalen College seeks Strategic Partner to accelerate development of The Oxford Science Park

Oxford, UK, May 10 2021 – Magdalen College Oxford, owner of The Oxford Science Park (TOSP), one of the UK’s leading parks for science and technology companies, has announced that it is seeking a strategic partner with which to accelerate development of the Park.

Amphista Therapeutics raises $53M in oversubscribed Series B round to advance next generation targeted protein degradation assets

Financing includes leading life-science investors Gilde Healthcare, Forbion, Novartis Venture Fund and Eli Lilly and Company

THE EPICENTRE OF THE DRUG INDUSTRY: HOW CROS’ BREADTH, TALENT, DIVERSITY AND EXPERTISE SUPPORTED UNPRECEDENTED SECTOR GROWTH TO BECOME THE BACKBONE OF BIOPHARMA

In recent years (CROs) have become the backbone of pharma and biotech research and development (R&D), the go-to source for in-depth know-how and niche expertise no longer available within such organisations. In recent years, the CRO sector has boomed. Despite being squeezed hard by COVID-19, according to new analysis out by Frost and Sullivan, the global market should still grow to $63.83 billion by 2024 from $43.03 billion in 2019, at a compound annual growth rate of 8.2%.